ICU Medical EBITDA Margin 2010-2025 | ICUI

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ICU Medical (ICUI) over the last 10 years. The current EBITDA margin for ICU Medical as of March 31, 2025 is .
ICU Medical EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $2.42B $0.29B 11.86%
2024-12-31 $2.38B $0.27B 11.34%
2024-09-30 $2.34B $0.23B 9.62%
2024-06-30 $2.30B $0.24B 10.50%
2024-03-31 $2.26B $0.24B 10.68%
2023-12-31 $2.26B $0.26B 11.47%
2023-09-30 $2.25B $0.27B 12.18%
2023-06-30 $2.29B $0.25B 10.94%
2023-03-31 $2.31B $0.26B 11.45%
2022-12-31 $2.28B $0.23B 9.91%
2022-09-30 $2.04B $0.21B 10.33%
2022-06-30 $1.78B $0.21B 11.90%
2022-03-31 $1.54B $0.19B 12.32%
2021-12-31 $1.32B $0.21B 16.25%
2021-09-30 $1.30B $0.22B 16.67%
2021-06-30 $1.28B $0.20B 15.48%
2021-03-31 $1.26B $0.19B 14.76%
2020-12-31 $1.27B $0.18B 14.48%
2020-09-30 $1.27B $0.17B 13.18%
2020-06-30 $1.26B $0.18B 14.18%
2020-03-31 $1.26B $0.18B 14.56%
2019-12-31 $1.27B $0.19B 14.61%
2019-09-30 $1.29B $0.16B 12.71%
2019-06-30 $1.31B $0.13B 10.00%
2019-03-31 $1.36B $0.13B 9.65%
2018-12-31 $1.40B $0.10B 7.43%
2018-09-30 $1.43B $0.16B 10.92%
2018-06-30 $1.45B $0.15B 10.31%
2018-03-31 $1.42B $0.08B 5.79%
2017-12-31 $1.29B $0.05B 4.18%
2017-09-30 $1.02B $0.01B 0.98%
2017-06-30 $0.77B $0.02B 3.10%
2017-03-31 $0.54B $0.07B 12.83%
2016-12-31 $0.38B $0.10B 27.11%
2016-09-30 $0.37B $0.10B 27.27%
2016-06-30 $0.36B $0.10B 28.37%
2016-03-31 $0.35B $0.10B 28.86%
2015-12-31 $0.34B $0.09B 26.10%
2015-09-30 $0.33B $0.09B 26.59%
2015-06-30 $0.32B $0.07B 22.67%
2015-03-31 $0.32B $0.06B 19.56%
2014-12-31 $0.31B $0.06B 19.42%
2014-09-30 $0.31B $0.06B 20.20%
2014-06-30 $0.31B $0.07B 22.04%
2014-03-31 $0.31B $0.07B 22.68%
2013-12-31 $0.31B $0.07B 23.25%
2013-09-30 $0.32B $0.08B 24.45%
2013-06-30 $0.32B $0.08B 25.24%
2013-03-31 $0.32B $0.08B 26.35%
2012-12-31 $0.32B $0.08B 26.18%
2012-09-30 $0.31B $0.09B 29.03%
2012-06-30 $0.31B $0.09B 27.87%
2012-03-31 $0.31B $0.09B 27.78%
2011-12-31 $0.30B $0.09B 28.24%
2011-09-30 $0.30B $0.07B 24.41%
2011-06-30 $0.30B $0.07B 24.75%
2011-03-31 $0.29B $0.07B 24.48%
2010-12-31 $0.28B $0.07B 22.97%
2010-09-30 $0.28B $0.06B 21.74%
2010-06-30 $0.25B $0.05B 20.87%
2010-03-31 $0.24B $0.05B 21.43%
2009-12-31 $0.23B $0.05B 23.68%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.197B $2.382B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $220.159B 25.82
Boston Scientific (BSX) United States $157.028B 37.51
Stryker (SYK) United States $154.023B 32.21
EssilorLuxottica (ESLOY) France $136.572B 0.00
Medtronic (MDT) Ireland $119.200B 16.90
Lonza Group Ag (LZAGY) Switzerland $50.282B 0.00
Haleon (HLN) United Kingdom $44.384B 25.33
ResMed (RMD) United States $40.346B 30.30
GE HealthCare Technologies (GEHC) United States $35.536B 16.87
Agilent Technologies (A) United States $34.139B 22.26
Terumo (TRUMY) Japan $25.843B 33.57
Koninklijke Philips (PHG) Netherlands $25.190B 17.68
Insulet (PODD) United States $20.424B 80.17
Zimmer Biomet Holdings (ZBH) United States $19.300B 12.40
Baxter (BAX) United States $14.995B 11.20
Smith & Nephew SNATS (SNN) United Kingdom $13.871B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $7.189B 25.02
Lantheus Holdings (LNTH) United States $5.046B 12.73
Perrigo (PRGO) Ireland $3.908B 9.91
Prestige Consumer Healthcare (PBH) United States $3.799B 16.97
Haemonetics (HAE) United States $3.613B 16.46
Envista Holdings (NVST) United States $3.525B 29.30
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
LeMaitre Vascular (LMAT) United States $1.862B 41.63
QuidelOrtho (QDEL) United States $1.852B 12.74
AtriCure (ATRC) United States $1.559B 0.00
Acuren (TIC) United States $1.441B 0.00
Green Thumb Industries (GTBIF) United States $1.332B 29.95
AdaptHealth (AHCO) United States $1.274B 12.93
Phibro Animal Health (PAHC) United States $1.183B 15.12
Neogen (NEOG) United States $1.133B 14.50
BioLife Solutions (BLFS) United States $1.080B 0.00
Curaleaf Holdings (CURLF) Canada $0.964B 0.00
InMode (INMD) Israel $0.930B 9.38
Kestra Medical Technologies (KMTS) United States $0.850B 0.00
Tilray Brands (TLRY) Canada $0.693B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.685B 0.00
Valneva SE (VALN) France $0.654B 0.00
Evolus (EOLS) United States $0.614B 0.00
Owens & Minor (OMI) United States $0.609B 5.05
CeriBell (CBLL) United States $0.547B 0.00
ZimVie (ZIMV) United States $0.521B 23.70
Surmodics (SRDX) United States $0.515B 0.00
SNDL (SNDL) Canada $0.398B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.359B 0.00
Cresco Labs (CRLBF) United States $0.336B 0.00
Sanuwave Health (SNWV) United States $0.324B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.89
Capricor Therapeutics (CAPR) United States $0.322B 0.00
Quanterix (QTRX) United States $0.292B 0.00
Aurora Cannabis (ACB) Canada $0.272B 80.67
Cerus (CERS) United States $0.266B 0.00
OraSure Technologies (OSUR) United States $0.251B 0.00
Viemed Healthcare (VMD) United States $0.242B 20.40
Biote (BTMD) United States $0.236B 6.65
Canopy Growth (CGC) Canada $0.234B 0.00
Verano Holdings (VRNOF) United States $0.230B 0.00
Sanara MedTech (SMTI) United States $0.227B 0.00
Omeros (OMER) United States $0.224B 0.00
Brainsway (BWAY) Israel $0.222B 58.65
Organigram Global (OGI) Canada $0.205B 0.00
Utah Medical Products (UTMD) United States $0.190B 15.65
High Tide (HITI) Canada $0.188B 0.00
TriSalus Life Sciences (TLSI) United States $0.173B 0.00
Vireo Growth (VREOF) United States $0.170B 0.00
Exagen (XGN) United States $0.155B 0.00
TerrAscend (TSNDF) Canada $0.135B 0.00
FitLife Brands (FTLF) United States $0.121B 14.91
MacroGenics (MGNX) United States $0.108B 0.00
Jin Medical (ZJYL) China $0.102B 0.00
Jushi Holdings (JUSHF) United States $0.101B 0.00
Fonar (FONR) United States $0.100B 12.86
Quipt Home Medical (QIPT) United States $0.097B 0.00
Apyx Medical (APYX) United States $0.096B 0.00
Safety Shot (SHOT) United States $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Veru (VERU) United States $0.082B 0.00
Zynex (ZYXI) United States $0.078B 0.00
Agape ATP (ATPC) $0.066B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.059B 0.00
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.038B 13.29
Nephros (NEPH) United States $0.038B 51.00
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.023B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Senestech (SNES) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00